teva

Welcome to the 'teva' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'teva'.

Are you an expert about 'teva'? Do you want to be the Technorati authority on 'teva'? You can write a description that will appear right here: Join Blogcritics!

Original Technorati articles tagged “teva”

• in Business
  Pharmaceutical Stocks Expected to Skyrocket in 2011
  2011 pharmaceutical stocks to take a look at.
  by caroline1234 / on Jan 25, 2011

Latest blogosphere posts tagged “teva”

 

• Teva Partnership And Pipeline Potential: Why Antares Is A Buy

  
  SeekingAlpha.com: Home Page — Authority: 529
  By Smith On Stocks : The failure of the Libi-Gel trial rocked the stock of Antares ( AIS ) and caused it to drop from around $2.62 to $1.67, with a subsequent recovery to $2.40. I think that this reaction failed to recognize the broad potential of the Antares product line beyond Libi-Gel. In particular, I think that ...
  5 days ago

• 13 Safest Foreign Dividend Stocks

  
  Dividend Yields — Authority: 421
  The Safest International Dividend Stocks by Dividend Yield - Stock, Capital, Investment. Here is a current sheet of foreign stocks with a beta ratio of less than 0.5. This means if the market changes one percent, the mentioned stock moves only 0.5 percent in the same direction and vice versa. In addition, the dividend ...
  1 week ago

• 12 Best Yielding NASDAQ Large Cap Dividend Stocks

  
  Dividend Yields — Authority: 421
  NASDAQ Large Capitalized Dividend Stocks With Cheap P/E Ratios Researched by Dividend Yield - Stock, Capital, Investment. Here is a current overview of the best yielding dividend stocks of NASDAQ listed companies with a market capitalization above USD 10 billion. 797 companies from the technology exchange NASDAQ pay ...
  1 week ago

• Investment Opportunities In 10 Big Pharmaceutical Companies

  
  SeekingAlpha.com: Home Page — Authority: 529
  By Marc Courtenay : "Theres nothing more powerful than an idea whose time has come", said Victor Hugo (1802-1885), recognized as the most influential French writer and poet of the 19th century. The man who brought us "Les Miserables" and "The Hunchback of Notre Dame" has been proven right on the above quote time ...
  1 week ago

• Takeda Plans To Cut 2,800 Jobs In US & Europe

  
  Pharmalot — Authority: 581
  Three months after completing its $13 billion acquisition of Nycomed, Takeda Pharmaceuticals now plans to cut roughly 10 percent of its workforce, or 2,800 jobs - about 2,100 from Europe and 700 from the US - by 2016 in order to save approximately $2.6 billion. The reorganization will include closing an unspecified ...
  1 week ago

• Hedge Fund Guru John Griffins Industry Leader High Growth Picks

  
  SeekingAlpha.com: Home Page — Authority: 529
  By Ganaxi Small Cap Movers : New York-based Hedge Fund Blue Ridge Capital Holdings LLC, headed by Guru, Tiger Cub and Star Manager John Griffin, manages $5.1 billion in U.S. equity assets, per its most recent SEC 13-F filing for the September 2011 quarter (for a detailed profile of the fund and Mr. Griffin, look ...
  1 week ago

• TheStreet Ratings Top 10 Rating Changes

  
  TheStreet.com — Authority: 594
  NEW YORK (TheStreet Ratings) -- Every trading day TheStreet Ratings stock model reviews the investment ratings on around 4,700 U.S. traded stocks for potential upgrades or downgrades based on the latest available financial results and trading activity. TheStreet Ratings released rating changes on 56 U.S. common ...
  2 weeks ago

• 5 High-Yield Healthcare Stocks Now On Sale

  
  SeekingAlpha.com: Home Page — Authority: 529
  By Stock Croc : While political fortunes will be determined this November in the United States, flattening the costs of healthcare will continue to be a priority no matter which political party ultimately gains control. This political reality can spell returns for investors who look for companies that make the most ...
  2 weeks ago

• Biogens Big Multiple Sclerosis Bet Is About To Be Rewarded ... Again

  
  SeekingAlpha.com: Home Page — Authority: 529
  A lot of drug companies have struggled to find their identity as competition and costs collide with profits. One of the best known biotech companies reinventing itself is Biogen Idec Inc. ( BIIB ), a $28 billion company highly leveraged to multiple sclerosis ("MS") through its Avonex and Tysabri drugs. Two years ...
  2 weeks ago

• CEL-SCI Corporation (CVM): Gearing Up For Something Bigger?

  
  The Market Playground — Authority: 463
  By VFC’s Stock House It’s been a little more than two years now since CEL-SCI Corporation (NYSEAMEX:CVM) made some real noise on the market, but recent events may be creating another perfect storm of news and attention that could spark new life into this potential big game play. Whether it was related to ...
  2 weeks ago

• Prolor Biotech: A Potentially Attractive Takeover Target

  
  SeekingAlpha.com: Home Page — Authority: 529
  By M.E. Garza : Shares of PROLOR Biotech, Inc. ( PBTH ) have been on the move and jumped another 4.5% on Friday after we told our premium subscribers that based on much of the chatter we heard at last weeks healthcare conferences in San Francisco, we continue to expect some very positive news flow from this ...
  2 weeks ago

• DiaPep277: Re-Educating the Immune System

  
  DiabetesMine: the all things diabetes blog — Authority: 458
  In the area of beta cell preservation, there’s a (sort of) new name in the spotlight: Andromeda Biotech, Ltd. with its DiaPep277 treatment. Based in Israel, this company announced last month that phase III clinical trials showed significant preservation of C-peptide…
  2 weeks ago

• Pharmalot… Pharmalittle… Our 5th Birthday

  
  Pharmalot — Authority: 581
  Good morning, everyone, and how are you today? We hope the weekend was refreshing and relaxing. Now, though, the routine of meetings and deadlines has resumed. We would like to pause, however, to note that today marks our fifth birthday - five years ago today, we launched Pharmalot . And it has been quite a ride. We ...
  2 weeks ago

• Questor Pharmaceuticals: Quickly Building A Multi-Billion Dollar Business

  
  SeekingAlpha.com: Home Page — Authority: 529
  By David White : Questor Pharmaceutical Inc. ( QCOR ) is a biopharmaceutical company that makes products for difficult to treat medical conditions. The companys efforts are currently focused on significant unmet needs in the fields of neurology and nephrology. The primary product is H.P. Acthar Gel (repository ...
  2 weeks ago

• TEVAs Neutroval: Are Biosimilars Coming To Antares Pharma?

  
  SeekingAlpha.com: Home Page — Authority: 529
  By James Stocklasar Thomas Jr. : While a lot of spurious fluff by would-be writers is being published about Antares Pharma ( AIS ), from a Teva ( TEVA ) SEC filing we read: “We plan to introduce additional products into the U.S. marketplace, and recently filed our first BLA for one such product, Neutroval TM ...
  2 weeks ago

• Shire, Prasco Ink Deal – Analyst Blog

  
  Stock Market News & Stocks to Watch from StraightStocks — Authority: 150
  Shire entered into an agreement with Prasco for US distribution rights to the generic version of Carbatrol
  2 weeks ago

• Where Has All the Propofol Gone?

  
  Law Med Blog — Authority: 106
   By Kurt Stone OpEdNews.com Propofol — one of the drugs that led to Michael Jackson’s untimely death — is a short-acting, intravenously administered hypnotic agent. Known in some circles as “Milk of Amnesia,” its uses include the induction and maintenance of general anesthesia, sedation for ...
  2 weeks ago

• 4 Undervalued Dividend Stocks To Buy, 1 To Avoid

  
  SeekingAlpha.com: Home Page — Authority: 529
  By Investment Underground : Every portfolio must have pharmaceutical exposure to provide stability. It is easier said than done to identify great dividend-yielding stocks that enhance your portfolio through a solid, regular income stream. There are a wide variety of factors to consider, from the size of the company, ...
  2 weeks ago

• Is Teva Pharmaceutical a Buffett Stock?

  
  Fool.com: The Motley Fool — Authority: 695
  Lets find out.
  2 weeks ago

• Why TEVAs Recent Momentum Will Continue Throughout 2012

  
  SeekingAlpha.com: Home Page — Authority: 529
  By Bret Jensen : Teva Pharmaceuticals ( TEVA ) has not been the best performer in my portfolio since I added a position in the stock during the third quarter of 2011. However, since TEVA went under $37 a share in late November, it has been on a solid roll. That momentum is accelerating over the last month and I ...
  2 weeks ago

Comments about teva